Regulation	O
of	O
the	O
resident	O
chromosomal	B-Cellular_component
copy	O
of	O
c	O
-	O
myc	O
by	O
c	O
-	O
Myb	O
is	O
involved	O
in	O
myeloid	B-Cell
leukemogenesis	O
.	O

c	O
-	O
myb	O
is	O
a	O
frequent	O
target	O
of	O
retroviral	O
insertional	O
mutagenesis	O
in	O
murine	O
leukemia	O
virus	O
-	O
induced	O
myeloid	B-Cancer
leukemia	I-Cancer
.	O

Induction	O
of	O
the	O
leukemogenic	O
phenotype	O
is	O
generally	O
associated	O
with	O
inappropriate	O
expression	O
of	O
this	O
transcriptional	O
regulator	O
.	O

Despite	O
intensive	O
investigations	O
,	O
the	O
target	O
genes	O
of	O
c	O
-	O
myb	O
that	O
are	O
specifically	O
involved	O
in	O
development	O
of	O
these	O
myeloid	B-Cell
lineage	O
neoplasms	B-Cancer
are	O
still	O
unknown	O
.	O

In	O
vitro	O
assays	O
have	O
indicated	O
that	O
c	O
-	O
myc	O
may	O
be	O
a	O
target	O
gene	O
of	O
c	O
-	O
Myb	O
;	O
however	O
,	O
regulation	O
of	O
the	O
resident	O
chromosomal	B-Cellular_component
gene	O
has	O
not	O
yet	O
been	O
demonstrated	O
.	O

To	O
address	O
this	O
question	O
further	O
,	O
we	O
analyzed	O
the	O
expression	O
of	O
c	O
-	O
myc	O
in	O
a	O
myeloblastic	B-Cell
cell	I-Cell
line	I-Cell
,	O
M1	B-Cell
,	O
expressing	O
a	O
conditionally	O
active	O
c	O
-	O
Myb	O
-	O
estrogen	O
receptor	O
fusion	O
protein	O
(	O
MybER	O
)	O
.	O

Activation	O
of	O
MybER	O
both	O
prevented	O
the	O
growth	O
arrest	O
induced	O
by	O
interleukin	O
-	O
6	O
(	O
IL	O
-	O
6	O
)	O
and	O
rapidly	O
restored	O
c	O
-	O
myc	O
expression	O
in	O
nearly	O
terminal	O
differentiated	O
cells	B-Cell
that	O
had	O
been	O
exposed	O
to	O
IL	O
-	O
6	O
for	O
3	O
days	O
.	O

Restoration	O
occurred	O
in	O
the	O
presence	O
of	O
a	O
protein	O
synthesis	O
inhibitor	O
but	O
not	O
after	O
a	O
transcriptional	O
block	O
,	O
indicating	O
that	O
c	O
-	O
myc	O
is	O
a	O
direct	O
,	O
transcriptionally	O
regulated	O
target	O
of	O
c	O
-	O
Myb	O
.	O

c	O
-	O
myc	O
is	O
a	O
major	O
target	O
that	O
transduces	O
Myb	O
'	O
s	O
proliferative	O
signal	O
,	O
as	O
shown	O
by	O
the	O
ability	O
of	O
a	O
c	O
-	O
Myc	O
-	O
estrogen	O
receptor	O
fusion	O
protein	O
alone	O
to	O
also	O
reverse	O
growth	O
arrest	O
in	O
this	O
system	O
.	O

To	O
investigate	O
the	O
possibility	O
that	O
this	O
regulatory	O
connection	O
contributes	O
to	O
Myb	O
'	O
s	O
oncogenicity	O
,	O
we	O
expressed	O
a	O
dominant	O
negative	O
Myb	O
in	O
the	O
myeloid	B-Cell
leukemic	I-Cell
cell	I-Cell
line	I-Cell
RI	I-Cell
-	I-Cell
4	I-Cell
-	I-Cell
11	I-Cell
.	O

In	O
this	O
cell	B-Cell
line	I-Cell
,	O
c	O
-	O
myb	O
is	O
activated	O
by	O
insertional	O
mutagenesis	O
and	O
cannot	O
be	O
effectively	O
down	O
regulated	O
by	O
cytokine	O
.	O

Myb	O
'	O
s	O
ability	O
to	O
regulate	O
c	O
-	O
myc	O
'	O
s	O
expression	O
was	O
also	O
demonstrated	O
in	O
these	O
cells	B-Cell
,	O
showing	O
a	O
mechanism	O
through	O
which	O
the	O
proto	O
-	O
oncogene	O
c	O
-	O
myb	O
can	O
exert	O
its	O
oncogenic	O
potential	O
in	O
myeloid	B-Cell
lineage	I-Cell
hematopoietic	I-Cell
cells	I-Cell
.	O

